Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder-Reply.
Autor: | Preskorn SH; Kansas University School of Medicine-Wichita., Risinger R; BioXcel Therapeutics Inc, New Haven, Connecticut., Kakar R; Segal Trials, Fort Lauderdale, Florida. |
---|---|
Jazyk: | angličtina |
Zdroj: | JAMA [JAMA] 2022 Jul 12; Vol. 328 (2), pp. 214-215. |
DOI: | 10.1001/jama.2022.8349 |
Databáze: | MEDLINE |
Externí odkaz: |